Genetic predisposition to cancer
- PMID: 6367981
Genetic predisposition to cancer
Abstract
A minor fraction of cancer occurs in persons who have strong dominantly transmissible genetic predisposition. Retinoblastoma and Wilms' tumor are the most thoroughly studied examples. Hereditary cases involve mutations at the same chromosomal sites. In most carriers of mutation the change cannot be visualized; in some, it is a visible deletion. A significant fraction of nonhereditary cases involve deletion at the same site in tumor cells only, suggesting that mutation at this site is necessary for the initiation of tumor, whether hereditary or not. This may be a general model for human cancer. The initiating mutation is not sufficient, however, since only rare cells are transformed. A second event may be genetic, such that recessive loss of the gene occurs. A two-event genetic model for a major fraction of human cancers is also compatible with the well-established, age-specific incidence of various cancers.
Similar articles
-
Prince Takamatsu memorial lecture. Rare cancers: clues to genetic mechanisms.Princess Takamatsu Symp. 1987;18:221-31. Princess Takamatsu Symp. 1987. PMID: 2852189 Review.
-
Genetics of embryonal tumours of childhood: retinoblastoma, Wilms' tumour and neuroblastoma.Cancer Surv. 1995;25:67-99. Cancer Surv. 1995. PMID: 8718513 Review.
-
Mutagenesis and embryonal carcinogenesis.Natl Cancer Inst Monogr. 1979 May;(51):19-24. Natl Cancer Inst Monogr. 1979. PMID: 225668
-
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.Oncologist. 1996;1(5):326-330. Oncologist. 1996. PMID: 10388011
-
Genetic and molecular aspects of human multigenerational carcinogenesis.IARC Sci Publ. 1989;(96):315-33. IARC Sci Publ. 1989. PMID: 2553599 Review.
Cited by
-
Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation.Oncogene. 2014 May 8;33(19):2487-94. doi: 10.1038/onc.2013.201. Epub 2013 Jun 24. Oncogene. 2014. PMID: 23792446 Free PMC article.
-
Molecular pathology of prostate cancer.J Clin Pathol. 2005 Jul;58(7):673-84. doi: 10.1136/jcp.2002.003954. J Clin Pathol. 2005. PMID: 15976331 Free PMC article. Review.
-
Hallmarks of Cancer Expression in Oral Leukoplakia: A Scoping Review of Systematic Reviews and Meta-Analyses.Cancers (Basel). 2025 Jul 22;17(15):2427. doi: 10.3390/cancers17152427. Cancers (Basel). 2025. PMID: 40805130 Free PMC article. Review.
-
Predictive Value of the Loss of pRb Expression in the Malignant Transformation Risk of Oral Potentially Malignant Disorders: A Systematic Review and Meta-Analysis.Cancers (Basel). 2025 Jan 20;17(2):329. doi: 10.3390/cancers17020329. Cancers (Basel). 2025. PMID: 39858110 Free PMC article. Review.
-
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.Breast Cancer Res. 2005;7(6):R998-1004. doi: 10.1186/bcr1337. Epub 2005 Oct 18. Breast Cancer Res. 2005. PMID: 16280054 Free PMC article.